Non-executive Director 

Theresa has over 25 years of experience in clinical research where she has led teams responsible for all aspects of clinical planning and delivery across oncology, haematology, and endocrinology therapeutic areas.

She has held executive positions in both clinical research organisations and biotechnology companies, including VP Clinical Operations at Chiltern and Senior VP of Clinical Operations at NuCana plc. Theresa currently holds the position of President, Clinical Operations with US-based Translations Drug Development (TD2), an oncology-focused contract research organization (CRO).